Skip to main content

Rheumatoid Arthritis Analysis by Nash Equilibrium Game Analysis

Buy Article:

$107.14 + tax (Refund Policy)

To effectively advance the evaluation of the pharmacokinetics and pharmacodynamics characteristics in treating rheumatoid arthritis, a profile analysis method was posed to analyze the pharmacokinetics and pharmacodynamics of rheumatoid arthritis with tripterygium by Nash equilibrium game analysis. The model fits the blood concentration of hydroxytriptolide and with robust parameter estimation. Findings exhibited that the higher the level of hemoglobin (HBG), the higher clearance of hydroxytriptolide will achieve. Of efficacy, ACR20 is significantly related to the body exposure to hydroxytriptolide (P < 0.05). For safety, the correlation between body exposure to hydroxytriptolide and adverse reactions, and adverse reactions of reproductive system in women at childbearing stage was not significantly related. The established population pharmacokinetic model satisfactorily expresses the pharmacokinetic profile of hydroxytriptolide in patients. The exposure to hydroxytriptolide was significantly correlated with ACR20 and adverse reactions of the reproductive system.

Keywords: GAME ANALYSIS; NASH EQUILIBRIUM; PHARMACODYNAMICS; PHARMACOKINETICS; PROFILE; RHEUMATOID; TRIPTERYGIUM WILFORDII

Document Type: Research Article

Publication date: 01 September 2019

More about this publication?
  • Journal of Medical Imaging and Health Informatics (JMIHI) is a medium to disseminate novel experimental and theoretical research results in the field of biomedicine, biology, clinical, rehabilitation engineering, medical image processing, bio-computing, D2H2, and other health related areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content